Eruptive xanthomas;Eruptive xanthome

Hautarzt

Volumn 55, Issue 10, 2004, Pages 978-980

  Roller, E ^a   Schulte, K W ^a   Hengge, U ^a   Ruzicka, T ^a   Kuhn, A ^a   Megahed, M ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Cardiovascular risk profile; Eruptive xanthomas; HMG CoA reductase inhibitor; Hyperlipidemia; Serum lipid values

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CASE REPORT; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; DIET THERAPY; ERUPTIVE XANTHOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; HYPERLIPIDEMIA FREDRICKSON TYPE IIB; LABORATORY TEST; MALE; PAPULE; XANTHOMA;

ADULT; BIOPSY; COMBINED MODALITY THERAPY; DIET, FAT-RESTRICTED; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPOPROTEINEMIA TYPE II; MALE; SKIN; XANTHOMATOSIS;

EID: 6344264993     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-004-0810-8     Document Type: Article

References (16)

1. Ackermann AB, Jacobson M, Vitale P (1991) Clues to diagnosis in dermatopathology. ASCP Press, Chicago
2. Borry P, Slack J (1974) A clinical syndrome characteristic of primary Type IV-V hyperlipoproteinemia. Br J Dermatol 90:245-253
3. Cooper PH (1986) Eruptive xanthoma: a microscopic simulator of granuloma anulare. J Cutan Pathol 13:207-215
4. Cruz PD JR, East C, Bergstresser PR(1988) Dermal, subcutaneous and tendon xanthomas: diagnostic markers for specific lipoprotein disorders. J Am Acad Dermatol 19:95-111
5. Dicken CH, Connollly SM (1980) Eruptive xanthomas associated with isotretinoin (13-cis-retinoid-acid). Arch Dermatol 116:951-952
6. Fredrickson DS, Lees RS (1965) A system for phenotyping hyperlipoproteinaemia. Circulation 31:321
7. Gofman JW, Rubin L, McGinley JP, Jones HB (1954) Hyperlipoproteinemia. Am J Med 17:514
8. Haber C, Kwiterovich PO (1984) Dyslipoproteinemia and xanthomatosis. Pediatric Dermatology 1:261-280
9. Herold G (2001) Lipidstoffwechselstörungen. In: Herold G (eds) Innere Medizin, pp 554-570
10. Lees RS, Hatch FT (1963) Sharper separation of lipoprotein species by paper electrophoresis in albumin-containing buffer. J Lab Clin Med 61:518
11. Lugo-Somolinos A, Sanchez JE (2003) Xanthomas: a marker for hyperlipidemias. Bol Asoc Med P R 95:12-16
12. Mancuso G, La Regina G, Bagnoli M et al. (1996) " Normolipidemic" tendinous and tuberous xanthomatosis. Dermatology 193:27-32
13. Nayak KR, Daly RG (2004) Eruptive xanthomas associated with hypertriglyceridemia and new-onset diabetes mellitus. N E J M 350:1235
14. Parker F (1985) Xanthomas and hyperlipidaemia. J Am Acad Dermatol 13:1-130
15. Polano MK (1974) Xanthomatosis and Hyperlipoproteinemia. A Review. Dermatologica 149:1-9
16. Rhinow K, Kalz S, Gelderblom HR, Reichart PA (2003) Verruciformes Xanthom. Mund Kiefer Gesichts Chir 7:52-55